G Kurt Hogaboom

Title: G Kurt Hogaboom: Innovator in Histamine Receptor Antagonism

Introduction

G Kurt Hogaboom is an accomplished inventor based in Morgantown, West Virginia. With a notable focus on the specific irreversibility of histamine receptor antagonism, Hogaboom has made significant contributions to medical science through his innovative work.

Latest Patents

Hogaboom holds one patent titled "Specific Irreversible Antagonism of Histamine Receptors by Photoaffinity." This patent outlines a specific method for irreversibly antagonizing histamine receptors, particularly H1 receptors, using a unique compound identified as 4(5)-[2-(4-azido-2-nitroanilino)ethyl]imidazole (AAH). The innovation utilizes photoaffinity characteristics that allow it to be actuated by light in the visible spectrum, presenting a novel approach to receptor antagonism.

Career Highlights

G Kurt Hogaboom's career has been primarily associated with the Department of Health in the United States. His research focuses on developing compounds capable of targeting and modulating histamine receptors, which play a crucial role in various physiological responses. The detailed formula mentioned in his patent reveals the chemical composition and potential applications in pharmacology.

Collaborations

Throughout his career, Hogaboom has collaborated with several notable colleagues, including Jeffrey S. Fedan and John P. O'Donnell. These professionals have contributed to the research and development efforts that support Hogaboom's innovative approaches to histamine receptor antagonism.

Conclusion

G Kurt Hogaboom's contributions to the field of receptor research underscore the importance of innovation in medical science. His patented method not only represents a significant achievement in pharmacological research but also holds promise for future developments in effective therapeutics targeting histamine-related conditions.